Evaluation of gefitinib efficacy according to body surface area in patients with non-small cell lung cancer harboring an EGFR mutationIGAWA, Satoshi; KASAJIMA, Masashi; KATONO, Ken et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 5, pp 939-946, issn 0344-5704, 8 p.Article

Prognostic Significance of Nestin Expression in Resected Non-small Cell Lung CancerRYUGE, Shinichiro; SATO, Yuichi; GUO QIN WANG et al.Chest (American College of Chest Physicians). 2011, Vol 139, Num 4, pp 862-869, issn 0012-3692, 8 p.Article

EGFR genetic heterogeneity of nonsmall cell lung cancers contributing to acquired gefitinib resistanceJIANG, Shi-Xu; YAMASHITA, Kazuya; OKAYASU, Isao et al.International journal of cancer. 2008, Vol 123, Num 11, pp 2480-2486, issn 0020-7136, 7 p.Article

Synthesis and pharmacological evaluation of 2-(3-piperidyl)-1,2,3,4-tetrahydroisoquinoline derivatives as specific bradycardic agentsKAKEFUDA, Akio; WATANABE, Toshihiro; TAGUCHI, Yasuko et al.Chemical and pharmaceutical bulletin. 2003, Vol 51, Num 4, pp 390-398, issn 0009-2363, 9 p.Article

Activation of Akt involves resistance to NF-_κB inhibition and abrogation of both triggers synergistic apoptosis in lung adenocarcinoma cellsTOGANO, Tomiteru; WATANABE, Mariko; ITOH, Kinji et al.Lung cancer. 2014, Vol 83, Num 2, pp 139-145, issn 0169-5002, 7 p.Article

Anti-HuC and -HuD autoantibodies are differential sero-diagnostic markers for small cell carcinoma from large cell neuroendocrine carcinoma of the lungMATSUMOTO, Toshihide; RYUGE, Shinichiro; MASUDA, Noriyuki et al.International journal of oncology. 2012, Vol 40, Num 6, pp 1957-1962, issn 1019-6439, 6 p.Article

Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lungRYUGE, Shinichiro; SATO, Yuichi; MASUDA, Noriyuki et al.Lung cancer. 2012, Vol 77, Num 2, pp 415-420, issn 0169-5002, 6 p.Article

Synergistic interactions between the synthetic retinoid tamibarotene and glucocorticoids in human myeloma cellsFUKUI, Tomoya; KODERA, Yasuo; NISHIO, Kazuto et al.Cancer science. 2009, Vol 100, Num 6, pp 1137-1143, issn 1347-9032, 7 p.Article

Evaluation of Amrubicin as a Third or Later Line of Chemotherapy for Advanced Non-Small Cell Lung CancerIGAWA, Satoshi; SASAKI, Jiichiro; ISHIHARA, Mikiko et al.Chemotherapy (Basel). 2013, Vol 59, Num 2, pp 99-105, issn 0009-3157, 7 p.Article

Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancerMASUDA, Noriyuki; NEGORO, Shunichi; FUKUOKA, Masahiro et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 3, pp 533-542, issn 0344-5704, 10 p.Article

Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomasNAGASHIO, Ryo; SATO, Yuichi; MATSUMOTO, Toshihide et al.Lung cancer. 2010, Vol 69, Num 1, pp 54-59, issn 0169-5002, 6 p.Article

Successful rechallenge with erlotinib in a patient with EGFR-mutant lung adenocarcinoma who developed gefitinib-related interstitial lung diseaseFUKUI, Tomoya; OTANI, Sakiko; HATAISHI, Ryuji et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 4, pp 803-806, issn 0344-5704, 4 p.Article

Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non-Small-Cell Lung CancerMARUYAMA, Riichiroh; NISHIWAKI, Yutaka; TAKEDA, Koji et al.Journal of clinical oncology. 2008, Vol 26, Num 26, pp 4244-4252, issn 0732-183X, 9 p.Article

Synthesis and pharmacological evaluation of 1-oxo-2-(3-piperidyl)-1,2,3,4-tetrahydroisoquinolines and related analogues as a new class of specific bradycardic agents possessing I_f channel inhibitory activityKUBOTA, Hideki; KAKEFUDA, Akio; WATANABE, Toshihiro et al.Journal of medicinal chemistry (Print). 2003, Vol 46, Num 22, pp 4728-4740, issn 0022-2623, 13 p.Article

The clinicopathological significance of Lgr5 expression in lung adenocarcinomaRYUGE, Shinichiro; SATO, Yuichi; JIANG, Shi-Xu et al.Lung cancer. 2013, Vol 82, Num 1, pp 143-148, issn 0169-5002, 6 p.Article

Phase I/II trial of gemcitabine plus oral TS-1 in elderly patients with advanced non-small cell lung cancer: Thoracic oncology research group study 0502SETO, Takashi; YAMANAKA, Takeharu; ICHINOSE, Yukito et al.Lung cancer. 2010, Vol 69, Num 2, pp 213-217, issn 0169-5002, 5 p.Article

Phase II Study of Erlotinib in Japanese Patients with Advanced Non-small Cell Lung CancerTAKAHASHI, Toshiaki; YAMAMOTO, Nobuyuki; SEGAWA, Yoshihiko et al.Anticancer research. 2010, Vol 30, Num 2, pp 557-563, issn 0250-7005, 7 p.Article

Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial GroupINOUE, Kenichi; NAKAGAMI, Kazuhiko; SHINKAI, Tetsu et al.Breast cancer research and treatment. 2010, Vol 119, Num 1, pp 127-136, issn 0167-6806, 10 p.Article

Low frequency oscillometry parameters in COPD patients are less variable during inspiration than during expirationKUBOTA, Masaru; SHIRAI, Gakuji; NAKAMORI, Tomoyuki et al.Respiratory physiology & neurobiology. 2009, Vol 166, Num 2, pp 73-79, issn 1569-9048, 7 p.Article

Relationship between N-linked oligosaccharide chains of human serum immunoglobulin G and serum tumor markers with non-small cell lung cancer progressionKANOH, Yuhsaku; OHARA, Tadashi; MASHIKO, Takaomi et al.Anticancer research. 2006, Vol 26, Num 6B, pp 4293-4297, issn 0250-7005, 5 p.Article

Carboplatin calculated with Chatelut's formula plus Etoposide for elderly patients with small-cell lung cancerMATSUI, Kaoru; MASUDA, Noriyuki; YANA, Takashi et al.Internal medicine (Tokyo. 1992). 2001, Vol 40, Num 7, pp 603-606, issn 0918-2918Article

Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancerASAKUMA, Maiko; YAMAMOTO, Michiko; IGAWA, Satoshi et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 6, pp 1529-1536, issn 0344-5704, 8 p.Article

The balance between the expressions of hASH1 and HES1 differs between large cell neuroendocrine carcinoma and small cell carcinoma of the lungNASGASHIO, Ryo; SATO, Yuichi; SAEGUSA, Makoto et al.Lung cancer. 2011, Vol 74, Num 3, pp 405-410, issn 0169-5002, 6 p.Article

Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid TumorsSATOH, Taroh; OKAMOTO, Isamu; SAITO, Toshikazu et al.Clinical cancer research (Print). 2009, Vol 15, Num 11, pp 3872-3880, issn 1078-0432, 9 p.Article

Gold cleaning methods for electrochemical detection applicationsFISCHER, Lee M; TENJE, Maria; HEISKANEN, Arto R et al.Microelectronic engineering. 2009, Vol 86, Num 4-6, pp 1282-1285, issn 0167-9317, 4 p.Conference Paper